Search clinical trials for: Mild to moderate allergic asthmatic adults

Total 477568 results

GlaxoSmithKline

Completed

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis | Hayfever

United States
GlaxoSmithKline

Completed

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma

Pulmonary Disease, Chronic Obstructive
Genentech, Inc.

Completed

A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma

Asthma
LEO Pharma

Completed

Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Germany
First Hospital of China Medical University

Completed

A Trial That Compound Clobetasol Propionate Ointment Treats Patients With Mild to Moderate Psoriasis Vulgaris.

Psoriasis
Fundació Institut de Recerca de l'Hospital de la...
Palo Biofarma, S.L

Completed

Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics

Asthma

Spain
Novartis

Withdrawn

Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma

Asthma
University of New Mexico
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Immune Dysregulation in Children and Adults With Asthma

Lung Diseases | Asthma
LEO Pharma

Completed

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Germany
Children's & Women's Health Centre of British Columbia

Withdrawn

Intranasal Mometasone in Children With Obstructive Sleep Apnea Due to Adenotonsillar Hypertrophy (Nasonex OSA)

Obstructive Sleep Apnea (Mild, Moderate, Severe) as Per Polysomnography

Canada
Kythera Biopharmaceuticals

Completed

Patient Experience Study of Deoxycholic Acid Injection

Moderate or Severe Submental Fullness

United States
Hadassah Medical Organization
Morria Biopharmaceuticals PLC

Completed

Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis

Allergic Contact Dermatitis

Israel
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Persistent Allergic Asthma

China
GlaxoSmithKline

Withdrawn

A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler

Asthma
Boehringer Ingelheim

Completed

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

Asthma
Revalesio Corporation

Completed

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma

Asthma

United States
Fougera Pharmaceuticals Inc.

Completed

Cutivate Lotion HPA Axis Pediatric Study

Atopic Dermatitis

United States
Boehringer Ingelheim

Completed

Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Liver Diseases | Healthy
Università degli Studi di Ferrara

Completed

Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

Asthma

Italy
Cytos Biotechnology AG

Withdrawn

CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids

Asthma

United States
The Hospital for Sick Children
Merck Frosst Canada Ltd.

Completed

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

Asthma, Bronchial

Canada
Genentech, Inc.

Completed

A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)

Asthma
AIM Therapeutics Inc.

Completed

Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma

Asthma

Canada
Washington University School of Medicine
Bristol-Myers Squibb

Completed

The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics (CIA)

Atopic Asthma

United States
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma

Asthma

United States
Creighton University
Novartis Pharmaceuticals

Completed

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair

Lung Disease

United States
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Terminated

A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada, Austria
JANSSEN Alzheimer Immunotherapy Research & Development...
Pfizer

Completed

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)

Alzheimer's Disease

United States, Germany, Canada, Austria
Pfizer

Completed

Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination

Pulmonary Disease, Chronic Obstructive

United States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
Sunovion

Completed

Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States
Genentech, Inc.

Completed

An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g

Asthma
Novartis
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma

Asthma

France
University of Bologna

Completed

Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children (SB-OSAS)

Obstructive Sleep Apnea Syndrome

Italy
GlaxoSmithKline

Completed

A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients

Asthma | Mild Asthma
Taiwan Otsuka Pharm. Co., Ltd

Completed

A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients

Asthma

Taiwan
Queen's University
GlaxoSmithKline

Completed

The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD

COPD

Canada
Children's Hospital Medical Center, Cincinnati

Withdrawn

Sildenafil Trial in Children and Young Adults With CF

Cystic Fibrosis With Mild to Moderate Lung Disease | CMRI of Lung Perfusion | Lung Perfusion | Lung Vascularization
Pharmaxis

Terminated

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients

Asthma

Canada
Pharmaxis

Completed

Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma

Asthma

Canada
AstraZeneca

Completed

Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma

Asthma

United States, United Kingdom
Jeanette Marketon, MD

Terminated

Ex Vivo Stimulation of Whole Blood as a Means to Determine Glucocorticoid Sensitivity to Mild-to-Moderate and Refractory Asthmatics

Asthma

United States
University of North Carolina, Chapel Hill
National Institutes of Health (NIH)

Terminated

Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma

Mild Allergic Rhinitis | Mild Allergic Rhinitis With Mild Asthma

United States
Derm Research, PLLC
Genentech, Inc.

Terminated

Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)

Plaque Psoriasis

United States
Amp Orthopedics, Inc.

Terminated

Effectiveness Study of the Ivivi SofPulse for Pain Amelioration in Adults With Mild to Moderate Knee Osteoarthritis

Knee Osteoarthritis

United States
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma

Asthma

United States
DiMango, Emily, M.D.
Novartis; Genentech, Inc.

Completed

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma

Asthma

United States
Sunovion

Completed

Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Genentech, Inc.

Completed

A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)

Asthma
Novartis
Genentech, Inc.

Completed

Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients

Asthma

3

Subscribe